Cargando…

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin

Detalles Bibliográficos
Autores principales:	Jonker, Jacqueline T, van der Meer, Rutger W, Rijzewijk, Luuk J, Menting, Lisa M, Diamant, Michaela, Romijn, Johannes A, Smit, Johannes WA, de Roos, Albert, Lamb, Hildo J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853825/ http://dx.doi.org/10.1186/1532-429X-11-S1-P113

Ejemplares similares

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
por: Jonker, Jacqueline T., et al.
Publicado: (2010)

Fatty liver in uncomplicated type 2 DM is associated with impaired myocardial HEP metabolism, modulated by myocardial glucose uptake
por: Jonker, Jacqueline T, et al.
Publicado: (2009)

Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism
por: Rijzewijk, Luuk J., et al.
Publicado: (2010)

Right Ventricular Involvement in Diabetic Cardiomyopathy
por: Widya, Ralph L., et al.
Publicado: (2013)

Right ventricular function and dimensions in type 2 diabetes mellitus
por: Widya, Ralph, et al.
Publicado: (2012)

Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes
por: Chen, Weena JY, et al.
Publicado: (2013)

Short-Term Hyperglycemic Dysregulation in Patients With Type 1 Diabetes Does Not Change Myocardial Triglyceride Content or Myocardial Function
por: Hammer, Sebastiaan, et al.
Publicado: (2008)

Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus
por: Jonker, Jacqueline, et al.
Publicado: (2011)

Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men
por: Chen, Weena JY, et al.
Publicado: (2011)

Long-term diet-induced, tissue-specific changes in (non)adipose triglyceride stores in obese patients with type 2 diabetes mellitus
por: Jonker, Jacqueline T, et al.
Publicado: (2011)

Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies
por: Greulich, Sabrina, et al.
Publicado: (2013)

Functional and metabolic imaging of the right ventricle: short-term caloric restriction increases myocardial triglyceride content and decreases diastolic heart function
por: Hammer, Sebastiaan, et al.
Publicado: (2012)

Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL
por: Wang, Yanan, et al.
Publicado: (2011)

Functional and Metabolic Imaging of the Cardiovascular System in Young Healthy South Asians and Caucasians Unveils Early Differences
por: van Schinkel, Linda D., et al.
Publicado: (2013)

Effects of Short-Term Nutritional Interventions on Right Ventricular Function in Healthy Men
por: Widya, Ralph L., et al.
Publicado: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Simultaneous Estimation of Metformin and Pioglitazone by Ultraviolet Spectrophotometry
por: Goswami, Laxmi, et al.
Publicado: (2010)

Formulation and Evaluation of Multilayered Tablets of Pioglitazone Hydrochloride and Metformin Hydrochloride
por: Chowdary, Y. Ankamma, et al.
Publicado: (2014)

Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Combination of Pioglitazone and Metformin Actions on Liver Lipid Metabolism in Obese Mice
por: Liu, Jieying, et al.
Publicado: (2023)

Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
por: Ohira, Masahiro, et al.
Publicado: (2014)

Comparative Study on Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin
por: Jameshorani, Maryam, et al.
Publicado: (2017)

Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
por: Esteghamati, Alireza, et al.
Publicado: (2013)

Short-Term Caloric Restriction Normalizes Hypothalamic Neuronal Responsiveness to Glucose Ingestion in Patients With Type 2 Diabetes
por: Teeuwisse, Wouter M., et al.
Publicado: (2012)

Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO study
por: van Eekelen, Esther, et al.
Publicado: (2019)

Evaluation of Osteopontin Gene Expression in Endometrium of Diabetic Rat Models Treated with Metformin and Pioglitazone
por: Hosseiny, Zeinab Sadat, et al.
Publicado: (2019)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
por: Xu, Yifeng, et al.
Publicado: (2017)

Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
por: Derosa, Giuseppe, et al.
Publicado: (2007)

Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions
por: Snel, M., et al.
Publicado: (2012)

Metabolomics: a search for biomarkers of visceral fat and liver fat content
por: Boone, Sebastiaan, et al.
Publicado: (2019)

Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women
por: Elffers, Theodora W., et al.
Publicado: (2017)

Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
por: Chawla, Shalini, et al.
Publicado: (2013)

Deduction of the operable design space of RP-HPLC technique for the simultaneous estimation of metformin, pioglitazone, and glimepiride
por: Marie, Aya A., et al.
Publicado: (2023)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Nutritional Status Differentially Alters Cytochrome P450 3A4 (CYP3A4) and Uridine 5′-Diphospho-Glucuronosyltransferase (UGT) Mediated Drug Metabolism: Effect of Short-Term Fasting and High Fat Diet on Midazolam Metabolism
por: Lammers, Laureen A., et al.
Publicado: (2018)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

Simultaneous Estimation of Metformin Hydrochloride and Pioglitazone Hydrochloride by RPHPLC Method from Combined Tablet Dosage Form
por: Sahoo, P. K., et al.
Publicado: (2008)

Development and validation of the liquid chromatographic method for simultaneous estimation of metformin, pioglitazone, and glimepiride in pharmaceutical dosage forms
por: Pandit, Vinay, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_t90p7b0tqfjor9c5ffd1botbhn